This article lists the top 10 reference products ranked by biosimilars in clinical and preclinical development for 2013. It is an evaluation of which biological products face the most potential competition from biosimilars currently in clinical development. More here. (Source: FirstWord Pharma, 7/8/13)
You are here: / Which biologics face the most competition from biosimilars?